vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and Enhabit, Inc. (EHAB). Click either name above to swap in a different company.
Enhabit, Inc. is the larger business by last-quarter revenue ($270.4M vs $236.8M, roughly 1.1× CROSS COUNTRY HEALTHCARE INC). Enhabit, Inc. runs the higher net margin — -14.3% vs -35.0%, a 20.7% gap on every dollar of revenue. On growth, Enhabit, Inc. posted the faster year-over-year revenue change (4.7% vs -23.6%). CROSS COUNTRY HEALTHCARE INC produced more free cash flow last quarter ($16.1M vs $3.3M). Over the past eight quarters, Enhabit, Inc.'s revenue compounded faster (1.5% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
CCRN vs EHAB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $270.4M |
| Net Profit | $-82.9M | $-38.7M |
| Gross Margin | — | — |
| Operating Margin | -30.2% | -12.3% |
| Net Margin | -35.0% | -14.3% |
| Revenue YoY | -23.6% | 4.7% |
| Net Profit YoY | -2109.7% | 15.9% |
| EPS (diluted) | $-2.56 | $-0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $270.4M | ||
| Q3 25 | $250.1M | $263.6M | ||
| Q2 25 | $274.1M | $266.1M | ||
| Q1 25 | $293.4M | $259.9M | ||
| Q4 24 | $309.9M | $258.2M | ||
| Q3 24 | $315.1M | $253.6M | ||
| Q2 24 | $339.8M | $260.6M | ||
| Q1 24 | $379.2M | $262.4M |
| Q4 25 | $-82.9M | $-38.7M | ||
| Q3 25 | $-4.8M | $11.1M | ||
| Q2 25 | $-6.7M | $5.2M | ||
| Q1 25 | $-490.0K | $17.8M | ||
| Q4 24 | $-3.8M | $-46.0M | ||
| Q3 24 | $2.6M | $-110.2M | ||
| Q2 24 | $-16.1M | $-200.0K | ||
| Q1 24 | $2.7M | $200.0K |
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 20.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 20.8% | — | ||
| Q1 24 | 20.4% | — |
| Q4 25 | -30.2% | -12.3% | ||
| Q3 25 | -2.4% | 6.4% | ||
| Q2 25 | -2.1% | 6.3% | ||
| Q1 25 | -0.3% | 6.1% | ||
| Q4 24 | -1.1% | -16.0% | ||
| Q3 24 | 0.9% | -38.6% | ||
| Q2 24 | -5.7% | 4.3% | ||
| Q1 24 | 0.8% | 4.9% |
| Q4 25 | -35.0% | -14.3% | ||
| Q3 25 | -1.9% | 4.2% | ||
| Q2 25 | -2.4% | 2.0% | ||
| Q1 25 | -0.2% | 6.8% | ||
| Q4 24 | -1.2% | -17.8% | ||
| Q3 24 | 0.8% | -43.5% | ||
| Q2 24 | -4.7% | -0.1% | ||
| Q1 24 | 0.7% | 0.1% |
| Q4 25 | $-2.56 | $-0.76 | ||
| Q3 25 | $-0.15 | $0.22 | ||
| Q2 25 | $-0.20 | $0.10 | ||
| Q1 25 | $-0.02 | $0.35 | ||
| Q4 24 | $-0.13 | $-0.92 | ||
| Q3 24 | $0.08 | $-2.20 | ||
| Q2 24 | $-0.47 | $0.00 | ||
| Q1 24 | $0.08 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $43.6M |
| Total DebtLower is stronger | — | $426.0M |
| Stockholders' EquityBook value | $322.8M | $534.0M |
| Total Assets | $449.0M | $1.2B |
| Debt / EquityLower = less leverage | — | 0.80× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $43.6M | ||
| Q3 25 | $99.1M | $56.9M | ||
| Q2 25 | $81.2M | $37.1M | ||
| Q1 25 | $80.7M | $39.5M | ||
| Q4 24 | $81.6M | $28.4M | ||
| Q3 24 | $64.0M | $45.7M | ||
| Q2 24 | $69.6M | $28.5M | ||
| Q1 24 | $5.2M | $36.5M |
| Q4 25 | — | $426.0M | ||
| Q3 25 | — | $441.5M | ||
| Q2 25 | — | $456.9M | ||
| Q1 25 | — | $467.3M | ||
| Q4 24 | — | $492.6M | ||
| Q3 24 | — | $502.9M | ||
| Q2 24 | — | $512.7M | ||
| Q1 24 | — | $526.7M |
| Q4 25 | $322.8M | $534.0M | ||
| Q3 25 | $408.1M | $566.8M | ||
| Q2 25 | $412.2M | $552.4M | ||
| Q1 25 | $418.2M | $543.2M | ||
| Q4 24 | $419.0M | $523.5M | ||
| Q3 24 | $424.7M | $566.1M | ||
| Q2 24 | $433.3M | $674.3M | ||
| Q1 24 | $462.4M | $672.3M |
| Q4 25 | $449.0M | $1.2B | ||
| Q3 25 | $538.2M | $1.2B | ||
| Q2 25 | $553.8M | $1.2B | ||
| Q1 25 | $576.2M | $1.2B | ||
| Q4 24 | $589.3M | $1.2B | ||
| Q3 24 | $597.4M | $1.3B | ||
| Q2 24 | $602.9M | $1.4B | ||
| Q1 24 | $648.4M | $1.4B |
| Q4 25 | — | 0.80× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.83× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | — | 0.94× | ||
| Q3 24 | — | 0.89× | ||
| Q2 24 | — | 0.76× | ||
| Q1 24 | — | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $4.4M |
| Free Cash FlowOCF − Capex | $16.1M | $3.3M |
| FCF MarginFCF / Revenue | 6.8% | 1.2% |
| Capex IntensityCapex / Revenue | 0.9% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $65.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $4.4M | ||
| Q3 25 | $20.1M | $37.8M | ||
| Q2 25 | $4.2M | $10.6M | ||
| Q1 25 | $5.7M | $17.9M | ||
| Q4 24 | $24.2M | $-4.1M | ||
| Q3 24 | $7.5M | $28.4M | ||
| Q2 24 | $82.4M | $9.6M | ||
| Q1 24 | $6.0M | $17.3M |
| Q4 25 | $16.1M | $3.3M | ||
| Q3 25 | $17.9M | $36.2M | ||
| Q2 25 | $2.3M | $8.7M | ||
| Q1 25 | $3.8M | $17.6M | ||
| Q4 24 | $21.7M | $-4.7M | ||
| Q3 24 | $6.3M | $27.7M | ||
| Q2 24 | $79.6M | $8.9M | ||
| Q1 24 | $3.8M | $15.5M |
| Q4 25 | 6.8% | 1.2% | ||
| Q3 25 | 7.2% | 13.7% | ||
| Q2 25 | 0.8% | 3.3% | ||
| Q1 25 | 1.3% | 6.8% | ||
| Q4 24 | 7.0% | -1.8% | ||
| Q3 24 | 2.0% | 10.9% | ||
| Q2 24 | 23.4% | 3.4% | ||
| Q1 24 | 1.0% | 5.9% |
| Q4 25 | 0.9% | 0.4% | ||
| Q3 25 | 0.9% | 0.6% | ||
| Q2 25 | 0.7% | 0.7% | ||
| Q1 25 | 0.6% | 0.1% | ||
| Q4 24 | 0.8% | 0.2% | ||
| Q3 24 | 0.4% | 0.3% | ||
| Q2 24 | 0.8% | 0.3% | ||
| Q1 24 | 0.6% | 0.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.41× | ||
| Q2 25 | — | 2.04× | ||
| Q1 25 | — | 1.01× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.23× | 86.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
